The DNA–PK complex also serves as a key regulator of hyperglycemia-induced endothelial ferroptosis in T2DM cardiomyopathy, potentially representing a novel therapeutic strategy to alleviate T2DM microvascular dysfunction and cardiac dysfunction [97]. The gene discussed is PRKDC; the disease is type 2 diabetes mellitus.